Radiofrequency-Assisted liver resection in cirrhotic patients with hepatocellular carcinoma
✍ Scribed by Giuseppe Curro; Long Jiao; Claudio Scisca; Umberto Baccarani; Massimo Mucciardi; Nagy Habib; Giuseppe Navarra
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 78 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Radio‐frequency‐assisted liver resection has been shown to allow virtually bloodless procedures without the need for vascular exclusion manoeuvres. Our primary end‐point was to evaluate safety and feasibility of RF‐assisted liver resection in cirrhotic patients with hepatocellular carcinoma. Our second end‐point was to assess whether the RF‐assisted procedure influence the outcome in terms of morbidity and mortality.
Methods
A retrospective study was done of 55 cirrhotic patients who underwent RF‐assisted liver resection for HCC at our Departments between September 2001 and October 2007.
Results
In the period of study 29 monosegmentectomies, 20 bisegmentectomies, 4 trisegmentectomies and 2 right hepatectomies were carried out. Vascular exclusion manoeuvres were never performed. One patient died post‐operatively because of untreatable hepatorenal syndrome. Twelve patients out of 55 experienced 21 complications including complicated pleural effusion, intra‐abdominal collection, hepatorenal syndrome, ascites, hematoma and biliary fistula. Post‐operative liver failure occurred in one case (1.8%). In patients without post‐operative morbidity (n = 43) the 4‐year survival rate was 62% versus 24% in patients who experienced post‐operative morbidity (n = 12) (P = 0.02).
Conclusions
RF‐assisted liver resection is a safe and feasible procedure associated with lower morbidity and hospital mortality rates even in case of liver cirrhosis. J. Surg. Oncol. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
An assessment was made of the frequency of liver cell dysplasia and the mean age of each group in 56 normal, 13 cirrhotic, and 50 hepatocellular carcinoma (HCC) patients, 40 with cirrhosis, from southern Africa. Dysplasia increased from 7.1% in normal subjects to 38.5% in cirrhotic, 40% in noncirrho
Hepatitis B virus (HBV) is an infection with highest prevalences in Asia and sub-Saharan regions of the world where temperatures may vary widely, and where cold storage is not readily available. These are also regions where universal vaccination against HBV infection is essential to break the long-s